BV
BioVaxys Technology Corp.
BVAXF · OTC
$0.09 -12.66% (-$0.01)
1M +10.43%
Market Cap $4.02M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.11
27.6% upside
Current Price
$0.086
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BVAXF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 435.65%
Asset turnover 0.00x
ROIC 138.40%
Debt
0 /100
High Current ratio 0.28x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
36 /100
Moderate EPS volatility 65.28%
Profitable years 0
Beta 1.09x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BVAXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Christopher Passin
Employees
3
Headquarters
Etobicoke